Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Delta opiod receptor signaling modulates myeloid suppression in Myelodysplastic Syndromes

Tiffany Razabdouski, KRIT Ritthipichai, Pingyan Cheng, Ruihua Chen, Bertrand Le Bourdonnec, Thierry Guillaudeux, Ken Wright, Alan List, James Bianco, Erika Eksioglu

Blood (2025) 146 (Supplement 1): 3841.

https://doi.org/10.1182/blood-2025-3841

Published: 2025

Journal Articles

Delta opioid receptor (DOR): A novel target for reprogramming tumor-associated macrophage (TAM) immunosuppressive phenotype to overcome acquired resistance and enhance the effectiveness of cancer immunotherapies

KRIT Ritthipichai, Ian Frank, Edward Garcia, Maya Jerald, Pingyan Cheng, Ruihua Chen, Tiffany Razabdouski, Erika Eksioglu, Bertrand Le Bourdonnec, Thierry Guillaudeux, James Bianco

Blood (2025) 146 (Supplement 1): 1201.

https://doi.org/10.1182/blood-2025-1201

Published: 2025

Journal Articles

Delta opioid receptor (DOR) expression on myeloid-derived suppressor cells (MDSCs) represents a novel target to overcome resistance to immune checkpoint inhibitors (ICIs)

Pingyan Cheng, Maya Jerald, Ian Frank, Edward Garcia, KRIT Ritthipichai, Ruihua Chen, Erika Eksioglu, Tiffany Razabdouski, Arjun Jayakrishnan, Bertrand Le Bourdonnec, Thierry Guillaudeux, James Bianco

Blood (2025) 146 (Supplement 1): 622.

https://doi.org/10.1182/blood-2025-622

Published: 2025

Journal Articles

Dysregulation of Splicing Patterns in MDS Induced By the S100A9/Fto Axis

Erika Adriana Eksioglu, MS PhD, Ling Cen, PhD, Xianghong Chen, PhD, Pingyan Cheng, MD, Kenneth Wright, PhD, Thu Le Trinh, PhD, Danielle Gilvary, BS, Wendy Kandell, BS, Jinhong Liu, MD, Yin-Kai Chen, MD, Amy F McLemore, M.S., Alexandra Calescibetta, John Cleveland, PhD, Alan F. List, MD, Sheng Wei, MD

Blood (2019) 134 (Supplement_1): 4215.

https://doi.org/10.1182/blood-2019-128434

Published: 2019

Journal Articles

S100A9 Contributes to T Cell Dysfunction through Its Interaction with RAGE in MDS

Wendy Kandell, BS, Thu Le Trinh, PhD, Xianghong Chen, PhD, Pingyan Cheng, MD, Danielle Gilvary, BS, Yin-Kai Chen, MD, Alexandra Calescibetta, Erika Adriana Eksioglu, MS PhD, Alan F. List, MD, Sheng Wei, MD

Blood (2019) 134 (Supplement_1): 4228.

https://doi.org/10.1182/blood-2019-128717

Published: 2019

Journal Articles

Immunodepletion of MDSC By AMV564, a Novel Tetravalent Bispecific CD33/CD3 T Cell Engager Restores Immune Homeostasis in MDS in Vitro

Pingyan Cheng, MD, Erika Eksioglu, PhD MS, Xianghong Chen, PhD, Max Wei, Jeanmarie Guenot, Judy Fox, Alan F List, MD, Sheng Wei, MD

Blood (2017) 130 (Supplement 1): 51.

https://doi.org/10.1182/blood.V130.Suppl_1.51.51

Published: 2017

Journal Articles

The S100A9/Fto Axis Induces Formation of RNA:DNA Hybrids That Serve As Damps Initiating Myeloid Skewing & Genetic Injury in MDS

Erika Eksioglu, PhD MS, Xianghong Chen, PhD, Pingyan Cheng, MD, Jinhong Liu, MD, Kathy McGraw, PhD, David A Sallman, MD, Eric Padron, MD, Alan F List, MD, Sheng Wei, MD

Blood (2017) 130 (Supplement 1): 52.

https://doi.org/10.1182/blood.V130.Suppl_1.52.52

Published: 2017

Journal Articles

Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands

Pingyan Cheng, Yulia Nefedova, Cesar A. Corzo, Dmitry I. Gabrilovich

Blood (2006) 109 (2): 507–515.

https://doi.org/10.1182/blood-2006-05-025601

Published: 2006

Includes: Supplemental data

Journal Articles

Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines

Yulia Nefedova, Pingyan Cheng, Melissa Alsina, William S. Dalton, Dmitry I. Gabrilovich

Blood (2004) 103 (9): 3503–3510.

https://doi.org/10.1182/blood-2003-07-2340

Published: 2004

Journal Articles

Notch signaling is necessary but not sufficient for differentiation of dendritic cells

Pingyan Cheng, Yulia Nefedova, Lucio Miele, Barbara A. Osborne, Dmitry Gabrilovich

Blood (2003) 102 (12): 3980–3988.

https://doi.org/10.1182/blood-2003-04-1034

Published: 2003

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Delta opiod receptor signaling modulates myeloid suppression in Myelodysplastic Syndromes

Delta opioid receptor (DOR): A novel target for reprogramming tumor-associated macrophage (TAM) immunosuppressive phenotype to overcome acquired resistance and enhance the effectiveness of cancer immunotherapies

Delta opioid receptor (DOR) expression on myeloid-derived suppressor cells (MDSCs) represents a novel target to overcome resistance to immune checkpoint inhibitors (ICIs)

Dysregulation of Splicing Patterns in MDS Induced By the S100A9/Fto Axis

S100A9 Contributes to T Cell Dysfunction through Its Interaction with RAGE in MDS

Immunodepletion of MDSC By AMV564, a Novel Tetravalent Bispecific CD33/CD3 T Cell Engager Restores Immune Homeostasis in MDS in Vitro

The S100A9/Fto Axis Induces Formation of RNA:DNA Hybrids That Serve As Damps Initiating Myeloid Skewing & Genetic Injury in MDS

Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands

Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines

Notch signaling is necessary but not sufficient for differentiation of dendritic cells

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only